Tenaya Therapeutics, Inc. (TNYA) Revenue History
Annual and quarterly revenue from 2019 to present
TNYA Revenue Over Time (2019–2025)
TNYA Revenue Growth History
- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $225K | — |
| Q4 2025 | $0 | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
TNYA Revenue Analysis (2019–2025)
Current Revenue & Growth
As of June 23, 2026, Tenaya Therapeutics, Inc. (TNYA) generated trailing twelve-month (TTM) revenue of $225,000. The most recent quarter (Q1 2026) recorded $225,000 in revenue
Historical Growth Trajectory
TNYA's historical revenue data shows various trends over time.
Peer Comparison
Compared to Healthcare sector peers — including SGMO (-45.8% YoY), EDIT (+8.0% YoY), and NTLA (+45.0% YoY). Compare TNYA vs SGMO →
TNYA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TNYACurrent | $225,000 | - | - | - | |
 SGMO | $40M | -45.8% | -19.7% | -273.1% | |
 EDIT | $41M | +8.0% | -14.9% | -245.2% | |
 NTLA | $68M | +45.0% | +3.1% | -651.7% | |
 BEAM | $140M | +108.0% | +466.3% | -274.6% |
TNYA Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-8,436,000 | - | $-93,331,000 | - |
| 2024 | $0 | - | $-8,468,000 | - | $-115,948,000 | - |
| 2023 | $0 | - | $-8,687,000 | - | $-131,193,000 | - |
| 2022 | $0 | - | $-8,713,000 | - | $-125,621,000 | - |
| 2021 | $0 | - | $-4,025,000 | - | $-72,806,000 | - |
| 2020 | $0 | - | $-2,483,000 | - | $-38,912,000 | - |
| 2019 | $0 | - | $-1,989,000 | - | $-27,712,000 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TNYA — Frequently Asked Questions
Quick answers to the most common questions about buying TNYA stock.
Is TNYA's revenue growth accelerating or slowing?
TNYA TTM revenue: $225000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is TNYA's revenue history from 2019 to 2026?
Tenaya Therapeutics, Inc. (TNYA) revenue history spans 2019 to 2026. TTM revenue as of 2026 is $225000.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is TNYA's long-term revenue growth rate (CAGR)?
Tenaya Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for TNYA.
Why does TNYA's quarterly revenue fluctuate?
TNYA quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Tenaya Therapeutics, Inc.'s revenue data from 2019 to 2026 shows full historical quarterly detail on this page.
How is TNYA's revenue distributed by segment?
TNYA reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does TNYA's revenue compare to industry peers?
Tenaya Therapeutics, Inc. (TNYA) with TTM revenue of $225000.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.